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Case Studies in Environmental Medicine
(CSEM): Disease Clusters: An Overview
Goals and Objectives
The goals of this CSEM are to increase the knowledge of health care
providers, especially pediatricians, of the special susceptibilities of
children to hazardous substances in the environment and to aid in their
evaluation of potentially exposed patients.
After completion of this educational activity, the reader should be able
to define a disease cluster, describe the components of the public health
department disease cluster investigation, and describe the physician’s
responsibility regarding disease clusters.
Accreditation
Continuing Medical Education (CME)
The Centers for Disease Control and Prevention (CDC) is accredited
by the Accreditation Council for Continuing Medical Education
(ACCME) to provide continuing medical education for physicians.
CDC designates this educational activity for a maximum of 1.5 hours in
category 1 credit toward the American Medical Association (AMA)
Physician’s Recognition Award. Each physician should claim only those
hours of credit that he/she actually spent in the educational activity.
Continuing Nursing Education (CNE)
This activity for 1.6 contact hours is provided by CDC, which is
accredited as a provider of continuing education in nursing by the
American Nurses Credentialing Center’s Commission on Accreditation.
Continuing Education Units (CEU)
CDC has been approved as an Authorized Provider of continuing
education and training programs by the International Association for
Continuing Education and Training and awards 0.1 continuing education
units (CEUs).
Continuing Health Education Specialist (CHES)
CDC is a designated provider of continuing education contact hours
(CECH) in health education by the National Commission for Health
Education Credentialing, Inc. This program is a designated event for the
CHES to receive 1.5 category 1 contact hours in health education.
Instructions
See page 4
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Instructions for Completing CSEM Online
1. Read this CSEM, Disease Clusters: An Overview; all answers are in the text.
2. Link to the MMWR/ATSDR Continuing Education General Information page (www.cdc.gov/atsdr/
index.html).
3. Once you access this page, select the Continuing Education Opportunities link.
4. Once you access the MMWR/ATSDR site online system, select the electronic file and/or register and test
for a particular ATSDR course.
a. Under the heading “Register and Take Exam,” click on the test type desired.
b. If you have registered in this system before, please use the same login and password. This will ensure
an accurate transcript.
c. If you have not previously registered in this system, please provide the registration information
requested. This allows accurate tracking for credit purposes. Please review the CDC Privacy Notice
(www.cdc.gov/privacy.htm).
d. Once you have logged in/registered, select the test and take the posttest.
5. Answer the questions presented. To receive continuing education credit, you must answer all of the
questions. Some questions have more than one answer. Questions with more than one answer will instruct
you to “indicate all that are true.”
6. Complete the course evaluation and posttest no later than September 29, 2008.
7. You will be able to immediately print your continuing education certificate from your personal transcript.
Instructions for Completing CSEM On Paper
1. Read this CSEM, Disease Clusters: An Overview; all answers are in the text.
2. Complete the evaluation questionnaire and posttest, including your name, mailing address, phone number,
and e-mail address, if available.
3. Circle your answers to the questions. To receive your continuing education credit, you must answer all of
the questions.
4. Sign and date the posttest.
5. Return the evaluation questionnaire and posttest, no later than September 1, 2008, to CDC by mail or
fax:
Mail or Fax
Continuing Education Coordinator                                                  770-488-4178
Division of Toxicology and                                                               ATTN: Continuing Education Coordinator
    Environmental Medicine, ATSDR
1600 Clifton Road, NE (MS F-32)
Atlanta, GA 30333
6. You will receive an award certificate within 90 days of submitting your credit forms. No fees are charged
for participating in this continuing education activity.
The questionnaire and posttest must be completed and returned electronically, by fax, or by mail
for eligibility to receive continuing education credit.
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Case Study
You are the senior partner in a busy suburban primary care practice. In
the past 30 days, three of the physicians in your practice have come to
you individually to discuss a case of concern. The cases are outlined
below:
Case 1
The patient is a 40-year-old second-grade schoolteacher who came in
for an annual checkup and breast exam. A mass was noted on her
mammogram. The patient is scheduled for stereotactic biopsy. She
expressed concerns that three other female teachers in her elementary
school have been diagnosed with breast cancer in the 4 years that the
school has been open. She is worried that working at the school might
have caused all or some of these cases. The elementary school was built
in an area that once housed several industrial facilities.
Case 2
The family practitioner in the group has a 35-year-old female
primigravida in her 10th week of pregnancy with vaginal bleeding. The
patient is concerned about the neighborhood where she has lived for
3 years. She recently learned in the past 4 years, six miscarriages in the
first trimester have occurred in her neighborhood of 100 women.
Case 3
An 87-year-old grandmother of three who came in for her annual
checkup had occult blood in her stool and is scheduled for a
colonoscopy with biopsy. She mentioned that three of her neighbors
from the active seniors club have been diagnosed with cancer in the past
2 years. She is concerned that living in her neighborhood is causing the
cancer.
These patients’ concerns and questions seem to have a common theme.
You are planning the next physician education conference for the
physicians in your practice and would like to discuss disease clusters
and pertinent patient education points.
Busy clinicians are often expected to respond to patient inquiries about
disease “cluster” events. Cluster events are groupings of a particular
disorder or a class of disorders, such as potentially related cancers, that
appear unusually frequent in a place. Such events pose challenges of
interpretation that differ from clinical evaluation of individual patients.
Accordingly, the goals of this monograph are to provide clinicians with a
framework for discussion of disease clusters.
Pretest
1. What is the definition of a
disease cluster?
2. Who investigates disease
clusters?
3. What happens in a disease
cluster investigation?
4. What is the physician’s
overall responsibility?
5. Who is the first-line
reporting contact?
6. What are the most important
points to discuss with your
patient regarding disease
clusters and occurrence of
disease?
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Definition of Disease Clusters
Unusual events such as clusters occur all the time, especially in large
populations. From a statistical perspective, it is almost inevitable that
some schools, church groups, friendship circles, and neighborhoods will
be associated with clusters of chronic diseases. When first noticed, such
clusters are often regarded as resulting from some specific, predictable
process, rather than as events with independent causes that happened to
have occurred by chance in one particular place (such as a coin toss).
A “cluster” is an unusual aggregation, real or perceived, of health events
that are grouped together in time and space and that is reported to a
public health department (CDC 1990). Several breakthroughs and
triumphs in infectious disease control have resulted from the
epidemiologic evaluation of clusters of cases.
Well-known examples of clusters include the epidemic of cholera in
London in the 1850s (Snow 1965), the investigation of cases of
pneumonia at the Bellevue-Stratford Hotel in Philadelphia in 1976
(Fraser et al. 1977), and the 1981 report that seven cases of
Pneumocystis carinii pneumonia had occurred among young
homosexual men in Los Angeles (CDC 1981).
Investigations of noninfectious disease clusters have also resulted in
notable examples of breakthroughs linking a particular health effect to an
exposure, such as angiosarcoma among vinyl chloride workers
(Waxweiler et al. 1976), neurotoxicity and infertility in kepone workers
(Cannon et al. 1978), dermatitis and skin cancer in persons wearing
radioactively contaminated gold rings (Baptiste et al. 1984),
adenocarcinoma of the vagina and maternal consumption of
diethylstilbestrol (Herbst et al. 1971), and phocomelia and consumption
of thalidomide (McBride 1961).
Disease clusters differ from sentinel events. Sentinel events are
occurrences of unexpected diseases or disorders that are known to
result from specific, recognized causes of likely relevance to the situation
or setting (Joint Commission on Accreditation of Healthcare
Organizations 2002). For example, the diagnosis of lead poisoning in a
child (a sentinel event) should suggest the likelihood of environmental
lead contamination that might affect other children. By contrast, disease
clusters are occurrences of seemingly unexpected diseases for which no
immediately apparent recognized cause exists.
Disease Clusters: An Overview
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Evaluating a Disease Cluster
The interface between the physician and the public health department is
essential in recognizing and responding to disease cluster concerns. It is
impractical for the busy clinician to perform epidemiologic and detailed
fact-finding. The public health department has expertise in evaluating
disease clusters.
It is essential to understand the components involved the public health
department investigation of a disease cluster and the physician’s role in
the process. The primary role of the physician is confirming diagnosis,
completing the exposure history when applicable, recognizing abnormal
patterns of events, and reporting information to the appropriate public
health department for investigation. Thus, the effective management of
disease clusters is initiated after case reporting by an astute clinician who
has completed the appropriate diagnostic tests and taken an exposure
history (Schuman 1997) (Figure 1).
An exposure history is of particular importance if the patient’s illness
(a) occurs at an atypical age, (b) is unresponsive to treatment, or (c) is
an acute condition where a direct link might exist between current
exposure and disease (e.g., asthma, first-trimester miscarriages, or
dermatologic conditions).
Figure 1. Effective Management of Disease Clusters
ATSDR, Agency for Toxic Substances and Disease Registry; CDC, Centers for Disease Control and
Prevention; MD, medical doctor.
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Table 1. Organs/Systems Often Affected by Toxic Exposure
Organ/System Exposure Risks
Respiratory Asbestos, radon, cigarette smoke, glues
Dermatologic Dioxin, nickel, arsenic, mercury, cement (chromium), polychlorinated
biphenyls (PCBs), glues, rubber cement
Liver Carbon tetrachloride, methylene chloride, vinyl chloride
Kidney Cadmium, lead, mercury, chlorinated hydrocarbon solvents
Cardiovascular Carbon monoxide, noise, tobacco smoke, physical stress, carbon disulfide,
nitrates, methylene chloride
Reproductive Methylmercury, carbon monoxide, lead, ethylene oxide
Hematologic Arsenic, benzene, nitrates, radiation
Neuropsychologic Tetrachloroethylene, mercury, arsenic, toluene, lead, methanol, noise,
vinyl chloride
These substances are examples of toxicants that might affect organ systems; this is not an all-inclusive list.
Bold type indicates that the substance is covered in one of the Case Studies in Environmental
Medicine.
The clinician must also keep in mind that many organ systems are
affected by toxic exposure (Table 1). Exposure and effects can be acute
or chronic. The latency period from exposure to manifestation of disease
can vary, ranging from immediate to delayed (hours or days) to
prolonged (decades). The exposure history is covered in detail in Case
Studies in Environmental Medicine: Taking an Exposure History
(ATSDR 2001). The exposure history form is included in Appendix A of
this case study.
The public health department’s role in the disease cluster investigation
involves
collecting accurate case information,
conducting active surveillance through local surveys or use of health
data registries,
conducting environmental or occupational exposure assessments
when warranted,
ensuring that appropriate public and health professional
communication and education occurs (specifically related to the
existence of a disease cluster and any associated factors), and
Disease Clusters: An Overview
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initiating timely and effective actions to mitigate factors associated
with the disease cluster.
An initial goal of the public health unit’s evaluation should be to decide
whether the cluster is “unusual” (i.e., whether an unexpectedly increased
incidence of disease really exists) and, if so, whether some plausible
biologic hypothesis can explain that unexpected disease rate. The public
health department can perform the following cluster evaluation
components (Figure 2):
Establish a case definition.
Confirm the suspected cases.
Define a “population denominator” measured in person-years and
search for additional numerator cases within that population. Draw
conclusions about the “unusualness” of the cases.
Review the literature for risk factors and exposure hypotheses.
Perform an exposure assessment.
Generate biologically plausible hypotheses.
Figure 2. Components of a Disease Cluster Evaluation
Disease Cluster Evaluation
Review the
Literature
Perform an
Exposure
Assessment
Define a
Population
Denominator in
Person-Years
Generate
Biologically
Plausible
Hypotheses
Establish Case
Definition
Confirm
Suspected
Cases
Case definition and
person-years are
defined on pages 10
and 11, respectively.
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Case Definition
The case definition is based on that which is most unusual about the
disease cluster under investigation. The choice of a case definition
depends on the information at hand. Often, several differing case
definitions exist that might be selected in light of what is initially known
about a presumed cluster.
Case definitions can be narrow or expanded. A narrow case definition
focuses on the most unusual or most coherent group of diseases
reported to affect the population of concern. An expanded case
definition would likely include a larger number of diseases that were
each likely to be related to one another by a common cause. For
example, if the public health department were evaluating a possible
cluster of an apparently infectious disease that resembled measles, they
might choose either a narrow case definition (such as children with fever,
cough, and morbilliform rash) or an expanded case definition (such as all
people with fever). In the case of the teacher with breast cancer,
evaluation of what seems unusual (the breast cancer cases) is most
appropriate.
Narrow definitions tend to exclude some cases that might be related to
the cluster. By contrast, expanded definitions often decrease the
possibility of finding an explanation for the cluster. It is more difficult to
hypothesize a unique cause for a variety of less-related diseases than for
a single disease or a homogeneous group of diseases.
Case definitions can group together diseases that might share common
causes: for example, the childhood cancer cases in Toms River
Township, New Jersey, with drinking water exposure, exposure to
ionizing radiation, or exposure to cigarette smoke. A case definition that
encompassed all of the outcomes known to be highly associated with
those exposures could be a rational choice in some cluster settings
(when the cause of a disease outbreak is known in advance, the disease
outbreak is more properly called a sentinel event, not a cluster). As a
general rule, expanded case definitions generally work best when
consistent scientific information exists about the presumed causal
exposure (as for cigarettes or radiation).
Case Confirmation
Once a case definition has been selected, it is then necessary to confirm
that those “cases” that defined the “cluster” really exist. It is essential to
confirm that all cases share some clearly defined set of symptoms,
physical findings, radiographic findings, and/or laboratory findings. The
Case definition has two
applications:
• for epidemiologic
surveillance studies
relating to the
prevalence of the
disease.
• for diagnostic purposes
using applicable
diagnostic features,
causes, and
pathophysiology.
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relevant importance of each type of information might vary depending on
the specific disease of concern, but the need for case confirmation
remains constant. The public health department’s role is to determine
and validate that the reported cases actually meet the case definition.
Many apparent clusters disappear at this stage of the cluster evaluation.
In some cases, it might be discovered that an apparent cluster is actually
an assortment of unrelated diseases and disease processes. For
example, a “brain cancer cluster” might actually be found to include
patients with metastases from distant sites, patients with nonneoplastic
infiltrative diseases, and even patients who have suffered strokes. Other
clusters might eventually be found to represent nothing but a random
pattern of incorrectly reported laboratory results or clinical findings, or
might reflect coding problems in hospital discharge summaries.
Define the Population
Denominator
Once an acceptable case definition exists and the reported cases have
been confirmed, the public health department will determine whether the
suspected cluster is actually “unusual.” This determination calls for an
explicit comparison between the number of cases actually observed and
the number that would have been expected under normal conditions.
The numerator cases (e.g., four teachers with breast cancers) must
ultimately be compared to some denominator population (e.g., expected
number of teachers diagnosed with breast cancer in such an elementary
school population). To make such comparisons, it is necessary to first
define the population at risk and then determine the number of cases
normally expected in that population. The public health epidemiologist
undertakes the task of defining the population at risk.
All clusters appear unusual when first discerned; yet most are due to
chance. Accordingly, it is necessary to restrain the natural tendency to
jump to causal conclusions. Among the most important initial concerns
are considerations of biologic plausibility. One aspect of such
considerations is to thoughtfully define the nature of the cluster; another
is to determine the scientific support for the obvious hypotheses.
Review the Literature
If the cluster is “unusual,” then it is appropriate to consider possible
causes for that cluster. The public health department would conduct a
thorough search of the relevant literature. The objective of this literature
Person-years are the most
frequently used measure of
person-time. Person-time is
the sum of individual units of
time that persons in the study
population have been
exposed to the condition of
interest. This measurement is
used as a denominator in
person-time incidence and
mortality rates.
With this approach, each
subject contributes only as
many years of observation to
the population at risk as he or
she is actually observed; if the
subject leaves after 2 years,
he or she contributes
2 person-years. This method
can be used to measure
incidence over extended and
variable time periods.
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review is to determine what is already known or hypothesized about the
cluster. Have similar clusters been observed and, if so, how common are
they? Have other individuals expressed concerns or documented
associations with any environmental exposures? Have previously
investigated clusters of the same or similar diseases yielded insights that
might be useful for understanding the cluster concerns you? What is
already well accepted about the causes of first-trimester miscarriages?
Exposure Assessment
After determining that the number of confirmed disease cases is in
excess of what is expected and reviewing the literature to identify
potential causes, the public health department will evaluate how
exposures might have occurred. The public health department conducts
an exposure assessment, which obtains basic information about the
proposed exposure sources. For example, the public health department
might investigate the following questions:
What chemicals, physical hazards, or biologic hazards are present?
What are the biologic effects of these chemicals or hazards? Have
any been associated in reputable scientific literature with the
disease(s) of concern?
Are there known or potential pathways by which these chemicals or
hazards might have impacted the population at risk? What were the
likely doses that resulted from such exposures?
In many cases, patient concerns focus on an exposure “source”—such
as a landfill, dump, or manufacturing facility—rather than on one or more
specific exposures that might have occurred.
Develop Biologically
Plausible Hypotheses
On completion of the exposure assessment, the public health department
will decide whether the available information is sufficient to generate a
biologically plausible hypothesis to explain the cluster.
To generate a biologically plausible hypothesis, the public health
department conducts structured interviews with each affected individual.
By means of standardized, structured questionnaires, each patient is
asked about medical history, family history, work history, hobbies and
Disease Clusters: An Overview
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other activities, lifestyle, historical exposures, and risks of exposures.
Some cluster investigations also delve into acquaintanceship patterns.
The interview results are carefully reviewed in an effort to find patterns
suggesting possible similarities linking the affected cases that can form
the basis of exposure hypotheses. Once common factors are identified
among the cases, a comparison of the affected individuals to randomly
selected groups of others from the denominator population can then test
the significance of such patterns.
Biologic plausibility might also depend on whether there is evidence of
shared exposure to a chemical capable of causing the disease of
concern, whether the exposures had been of sufficient magnitude to
cause adverse effects, and whether all affected individuals had been
exposed. Additionally, the temporal relationship between exposure and
effect should be evaluated in terms of what information is known. Many
diseases such as cancers develop only after a delay (or latency period)
lasting years or, more often, decades. (Latency period is the duration of
time from first exposure to first symptoms or signs of a disease.) For
that reason, it would not be biologically plausible to link very recent
exposure to the onset of cancer.
Clinicians in communities affected by disease clusters have an important
role in understanding and translating the science of cluster investigations
and an equally important role in reporting possible disease clusters to the
local public health units in their practice communities.
The physician’s responsibility is to
Suspect a cluster of disease based on clinical observation.
Complete an exposure history.
Confirm case(s) through accurate clinical and laboratory diagnosis.
Act as a sentinel in reporting cases to the local public health
department.
Educate patients about occurrence of disease.
The first line for contact is the public health department. The public
health department can initiate
active surveillance,
exposure assessments, and
development of local registries.
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Risk Communication: Sample Patient
Education Scenario
Doctor: Your mammogram illustrates two abnormal areas that I would like to explore further by performing a
biopsy. The biopsy will show whether the tissue is malignant or benign.
Patient: Four teachers at my school have been diagnosed with breast cancer in the past 4 years that the
school has been open.
Doctor: Ms. Jones, cancer develops over a long period of time—decades—and it is important to know the
family history. A percentage of cancer cases are inherited and recent research has identified changes
(mutations) in two genes that greatly increase the risk for breast cancer.
Patient: So are you saying it is unlikely that the school is the cause of my cancer?
Doctor: First, I am not diagnosing you with cancer at this time. You have two abnormal areas that need to be
biopsied so that we can determine whether the tissue is cancerous or not.
Patient: What about the school?
Doctor: It is highly unlikely that the school would be the cause because the school has only been open for 4
years. The latency period for cancer can be decades.
Patient: I understand. When do you want to schedule the biopsy?
The most important points to discuss during patient education are
The current problem and the next appropriate diagnostic step.
Specific factors related to the occurrence of the particular disease (e.g., latency period for cancer,
significance of family history, and other confounding factors).
Whether it is likely or unlikely that the patient’s perceived exposure might be responsible for the problem:
If it is likely, discuss your role and responsibility.
Following are specific clinical points based on the case study scenarios.
In case scenario 1, the possibility would be unlikely that the breast cancer was caused by exposures in the
school, which has only been open for 4 years. Successful cluster investigations most often involve a high
occurrence of uncommon diseases.
In case scenario 2, the possibility would be unlikely that the miscarriages are caused by the neighborhood.
Spontaneous abortion occurs in 10%–14% of pregnancies in women. Statistically, it would be expected that
spontaneous abortion would occur in 10–14 of 100 women. Recurrent spontaneous abortions (defined as the
Disease Clusters: An Overview
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loss of three or more consecutive pregnancies) occur in about 3%–4% of these women. Most spontaneous
abortions occur because of abnormalities in the fetus (Matorras et al. 1998).
In case scenario 3, the possibility would be unlikely that the cancers are directly related to living in the
neighborhood. The latency period for cancer can be decades. Additionally, several confounding factors
including smoking, family history of cancer (particularly breast cancer), and potential workplace exposures
must be explored in the medical history, family history, and exposure history before attempting to consider
that the cancer rates in this neighborhood are related to a neighborhood exposure.
Most cluster associations result from coincidence and chance, but that does not mean that clusters are not
useful sources of information. Numerous instances exist where reports of a disease cluster led to recognition
of a new disease-causing agent or environment. Some examples from the occupational medicine literature
include the associations of vinyl chloride monomer with angiosarcoma of the liver, dibromochloropropane with
male infertility, and bis-chloromethyl ether with small-cell lung cancer in young men. Table 2 shows a list of
other examples, such as human disease caused by toxicants, organisms, and dusts.
Clusters provide opportunities and impetus for developing new hypotheses about previously unsuspected
exposure-outcome relationships. Some of these new hypotheses lead to better understanding of disease
causation. Disease clusters help us to identify previously unrecognized hazards.
Table 2. Examples* of Community Clusters Leading to the Identification of New Exposure-
Disease Relationships
Population Year Exposure Outcomes
Rural dwellers 1928 Castor bean dust Asthma
Harbor dwellers 1989 Soybean dust Asthma
Children and adults 1979, Polychlorinated biphenyls Developmental, central
  1989 nervous system, lipid
disorders
Homosexual males 1981 Human immunodeficiency virus (HIV) Pneumocystis carinii
opportunistic infection
Drug users 1983 N-methyl-4-phenyl-1,2,5,6- Parkinson-like
symptoms tetrahydropyridine
Health food consumers 1989 L-tryptophan (contaminated) Eosinophilia-myalgia
Fish handlers and
estuarine visitors 1995 Pfiesteria piscicida Memory disturbance
Dieters 1997 Fenfluramine-Phentermine Valvular heart disease
*More examples of clusters, and many more of sentinel events, are available.
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Web Resources
Association of Occupational and Environmental Clinics (AOEC) at www.aoec.org or 202-347-4976.
Agency for Toxic Substances and Disease Registry (ATSDR). For general information, contact
www.atsdr.cdc.gov or toll-free (1-888-42-ATSDR or 1-888-422-8737). The ATSDR Emergency Response
24-hour hotline number is 404-498-0120.
Fleming LE. Disease clusters in occupational and environmental health. Available from URL:
www.pighealth.com/Scourse/lecture/lec0351/index.htm.
National Institute for Occupational Safety and Health (NIOSH) at www.cdc.gov/niosh or toll-free (1-800-
35-NIOSH or 1-800-356-4674).
National Research Council (NRC) at www.nationalacademies.org/nrc/.
Occupational Safety and Health Administration (OSHA) at www.osha.gov or emergency toll-free 1-800-
321-OSHA (1-800-321-6742).
Pediatric Environmental Health Specialty Units (PEHSUs) at www.aoec.org/pesu.htm or 202-347-4976
(AOEC office).
State and local health departments, toxicologists, and industrial hygienists.
U.S. Environmental Protection Agency (EPA) at www.epa.gov.
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Answers to Pretest Questions
1. The term “cluster” is an unusual aggregation, real or perceived, of health events that are grouped together in
time and space and that are reported to a public health unit.
2. The public health department investigates disease clusters. The public health department’s role in the disease
cluster investigation involves the following:
collecting accurate case information,
conducting active surveillance through local surveys or by using health data registries,
conducting environmental or occupational exposure assessments when warranted,
ensuring that appropriate public and health professional communication and education is occurring
specifically related to the existence of a disease cluster and any associated factors, and
initiating timely and effective actions to mitigate factors associated with the disease cluster.
3. The steps involved in a disease cluster investigation are (1) establish a case definition; (2) confirm the
suspected cases; (3) define a “population denominator” measured in person-years, search for additional
numerator cases within that population, and draw conclusions about the “unusualness” of the cases; (4) review
the literature for risk factors and exposure hypotheses; (5) perform an exposure assessment; and (6) generate
biologically plausible hypotheses.
4. The physician’s overall responsibility is to suspect a cluster of disease on the basis of clinical observation,
complete an exposure history, confirm cases through accurate clinical and laboratory diagnosis, act as a
sentinel in reporting cases to the local public health unit, and educate patients about occurrence of disease.
5. The first line for contact is usually the public health department.
6. Following are the most important education points:
The current problem and the next appropriate diagnostic step.
Specific factors related to the occurrence of the particular disease (e.g., latency period for cancer,
significance of family history, and other confounding factors).
Whether it is likely or unlikely that the patient’s perceived exposure might be responsible for the problem;
if it is likely, discuss your role and responsibility.
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Case Studies in Environmental Medicine:
Disease Clusters: An Overview
Evaluation Questionnaire and Posttest, Course Number SS3096
Course Goal: To increase the primary care provider’s knowledge of hazardous substances in the environment
and to aid in the evaluation of potentially exposed patients.
Objectives
Define a disease cluster.
Describe the components of the public health department disease cluster investigation.
Describe the physician’s responsibility regarding disease clusters.
Tell Us About Yourself
Please carefully read the questions. Provide answers on the answer sheet (page 25). Your credit will
be awarded based on the type of credit you select.
1. What type of continuing education credit do you wish to receive?
**Nurses should request CNE, not CEU. See note on page 24.
A. CME (for physicians)
B. CME (for non-attending)
C. CNE (continuing nursing education)
D. CEU (continuing education units)
E. [Not used]
F. [Not used]
G. [Not used]
H. None of the above
I. CHES (certified health education specialist)
2. Are you a...
A. Nurse
B. Pharmacist
C. Physician
D. Veterinarian
E. None of the above
3. What is your highest level of education?
A. High school or equivalent
B. Associate, 2-year degree
C. Bachelor’s degree
D. Master’s degree
E. Doctorate
F. Other
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4. Which of the following best describes your current occupation?
A. Environmental Health Professional
B. Epidemiologist
C. Health Educator
D. Laboratorian
E. Physician Assistant
F. Industrial Hygienist
G. Sanitarian
H. Toxicologist
I. Other patient care provider
J. Student
K. None of the above
5. Which of the following best describes your current work setting?
A. Academic (public and private)
B. Private health care organization
C. Public health organization
D. Environmental health organization
E. Non-profit organization
F. Other work setting
6. Which of the following best describes the organization in which you work?
A. Federal government
B. State government
C. County government
D. Local government
E. Non-governmental agency
F. Other type of organization
Tell Us About the Course
7. How did you obtain this course?
A. Downloaded or printed from Web site
B. Shared materials with colleague(s)
C. By mail from ATSDR
D. Not applicable
8. How did you first learn about this course?
A. State publication (or other state-sponsored communication)
B. MMWR
C. ATSDR Internet site or homepage
D. PHTN source (PHTN Web site, e-mail announcement)
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E. Colleague
F. Other
9. What was the most important factor in your decision to obtain this course?
A. Content
B. Continuing education credit
C. Supervisor recommended
D. Previous participation in ATSDR training
E. Previous participation in CDC and PHTN training
F. Ability to take the course at my convenience
G. Other
10. How much time did you spend completing the course, evaluation, and posttest?
A. 1 to 1.5 hours
B. More than 1.5 hours but less than 2 hours
C. 2 to 2.5 hours
D. More than 2.5 hours but less than 3 hours
E. 3 hours or more
11. Please rate your level of knowledge before completing this course.
A. Great deal of knowledge about the content
B. Fair amount of knowledge about the content
C. Limited knowledge about the content
D. No prior knowledge about the content
E. No opinion
12. Please estimate your knowledge gain after completing this course.
A. Gained a great deal of knowledge about the content
B. Gained a fair amount of knowledge about the content
C. Gained a limited amount of knowledge about the content
D. Did not gain any knowledge about the content
E. No opinion
Please use the scale below to rate your level of agreement with the following statements
(questions 13–21) about this course.
A. Agree
B. No opinion
C. Disagree
D. Not applicable
13. The objectives are relevant to the goal.
14. The tables and figures are an effective learning resource.
15. The content in this course was appropriate for my training needs.
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16. Participation in this course enhanced my professional effectiveness.
17. I will recommend this course to my colleagues.
18. Overall, this course enhanced my ability to understand the content.
19. I am confident I can define a disease cluster.
20. I am confident I can describe the components of the public health department disease cluster
investigation.
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21. I am confident I can describe the physician’s responsibility regarding disease clusters.
Posttest
If you wish to receive continuing education credit for this program, you must complete this posttest. Each
question below contains five suggested answers, of which one or more is correct. Circle all correct answers
on the answer sheet.
22. Disease clusters are best characterized by
A. absence of exposure hypotheses.
B. an unusual aggregation, real or perceived, of health events that are grouped together in time and space
and that are reported to a public health unit.
C. community group.
D. proximity to waste sites.
E. awkward communications.
23. A component of a cluster investigation includes
A. creating a testable exposure hypothesis.
B. safeguarding public health funds.
C. performing an effective risk assessment.
D. ensuring that all stakeholders reach a compromise outcome.
E. closing the case.
24. Which of the following disease-exposure relationships was first characterized by cluster reports?
A. Angiosarcoma of the liver from vinyl chloride.
B. Adenocarcinoma of the vagina and maternal consumption of diethylstilbestrol.
C. Phocomelia and maternal consumption of thalidomide.
D. Neurotoxicity from chlordecone (kepone).
E. All of the above.
25. Which of the following conditions is most likely to describe a disease cluster with a clearly
identifiable environmental cause?
A. Excess of a common disease in a large population.
B. Excess of a common disease in a small population.
C. Excess of a rare disease in a large population.
D. Excess of a rare disease in a small population.
E. Excess of several different common diseases in a large population.
26. The case definition can be
A. narrow.
B. expanded.
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C. based on that which is most unusual about the disease cluster under investigation.
D. a choice that depends on the information at hand.
E. all of the above.
27. The federal agency that conducts evaluations of human health outcomes from toxic waste is the
A. U.S. Environmental Protection Agency.
B. Office of the Surgeon General.
C. Agency for Toxic Substances and Disease Registry.
D. National Institute for Occupational Safety and Health.
E. Bureau of Land Management.
28. The physician’s overall responsibility includes
A. suspecting a cluster of disease based upon clinical observation.
B. completing an exposure history.
C. confirmation of case(s) through accurate clinical and laboratory diagnosis.
D. acting as a sentinel in reporting cases to the local public health unit.
E. all of the above.
29. The public health department initiates
A. active surveillance.
B. exposure assessments.
C. development of local registries.
D. all of the above.
E. none of the above.
Note to Nurses
CDC is accredited by the American Nurses Credentialing Center’s (ANCC) Commission on
Accreditation. ANCC credit is accepted by most State Boards of Nursing.
California nurses should write in “ANCC - Self-Study” for this course when applying for relicensure. A
provider number is not needed.
Iowa nurses must be granted special approval from the Iowa Board of Nursing. Call 515-281-4823 or e-
mail marmago@bon.state.ia.us to obtain the necessary application.
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Case Studies in Environmental Medicine:
Disease Clusters: An Overview
Answer Sheet, Course Number SS3096
Instructions for submitting hard-copy answer sheet: Circle
your answers. To receive your certificate, you must answer all
questions. Mail or fax your completed answer sheet to
Fax: 770-488-4178, ATTN: Continuing Education Coordinator
Mail: Continuing Education Coordinator
Agency for Toxic Substances and Disease Registry
Division of Toxicology and Environmental Medicine
1600 Clifton Road, NE (MS F-32)
Atlanta, GA 30333
Be sure to fill in your name and address on the back of this
form.
Remember, you can access the
case studies online at
www.atsdr.cdc.gov/HEC/CSEM/
and complete the evaluation
questionnaire and posttest
online at www2.cdc.gov/
atsdrce/.
Online access allows you to
receive your certificate as soon
as you complete the posttest.
1. A B C D E F G H I
2. A B C D E
3. A B C D E F G
4. A B C D E F G H I J K
5. A B C D E F
6. A B C D E F
7. A B C D
8. A B C D E F
9. A B C D E F G
10. A B C D E
11. A B C D E
12. A B C D E
13. A B C D
14. A B C D
15. A B C D
16. A B C D
17. A B C D
18. A B C D
19. A B C D
20. A B C D
21. A B C D
22. A B C D E
23. A B C D E
24. A B C D E
25. A B C D E
26. A B C D E
27. A B C D E
28. A B C D E
29. A B C D E
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Continuing Education Coordinator
Agency for Toxic Substances and Disease Registry
Division of Toxicology and Environmental Medicine
1600 Clifton Road, NE (MS F-32)
Atlanta, GA 30333
Place
Stamp
Here
fold here first
fold here second
tape or staple here
Name: E-mail (not required):
Address:
Zip code:
Check here to be placed on the list to
pilot test new case studies
Access the case studies online at www.atsdr.cdc.gov/
HEC/CSEM/ and complete the evaluation questionnaire
and posttest online at www2.cdc.gov/atsdrce/.
Online access allows you to receive your certificate as
soon as you complete the posttest.
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Appendix A: Exposure History Form
Part 1. Exposure Survey Name: Date:
Please circle the appropriate answer. Birth date:         Sex (circle one): Male         Female
1. Are you currently exposed to any of the following?
metals no yes
dust or fibers no yes
chemicals no yes
fumes no yes
radiation no yes
biologic agents no yes
loud noise, vibration, extreme heat or cold no yes
2. Have you been exposed to any of the above in the past? no yes
3. Do any household members have contact with metals,
dust, fibers, chemicals, fumes, radiation, or biologic agents? no yes
If you answered yes to any of the items above, describe your exposure in detail—how you were exposed,
to what you were exposed. If you need more space, please use a separate sheet of paper.
4. Do you know the names of the metals, dusts, fibers,
chemicals, fumes, or radiation that you are/were
exposed to? no    yes
5. Do you get the material on your skin or clothing? no    yes
6. Are your work clothes laundered at home? no    yes
7. Do you shower at work? no    yes
8. Can you smell the chemical or material you are
working with? no    yes
9. Do you use protective equipment such as gloves,
masks, respirator, or hearing protectors? no    yes
10.Have you been advised to use protective
equipment? no    yes
11. Have you been instructed in the use of protective
equipment? no    yes
If yes, list them below.
If yes, list the protective
equipment used.
Developed by ATSDR in cooperation with NIOSH, 1992
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12. Do you wash your hands with solvents? no    yes
13. Do you smoke at the workplace? no    yes
At home? no    yes
14. Are you exposed to secondhand tobacco smoke at the workplace? no    yes
At home? no    yes
15. Do you eat at the workplace? no    yes
16. Do you know of any co-workers experiencing similar or unusual symptoms? no    yes
17. Are family members experiencing similar or unusual symptoms? no    yes
18. Has there been a change in the health or behavior of family pets? no    yes
19. Do your symptoms seem to be aggravated by a specific activity? no    yes
20. Do your symptoms get either worse or better at work? no    yes
at home? no    yes
on weekends? no    yes
on vacation? no    yes
21. Has anything about your job changed in recent months (such as duties,
procedures, overtime)? no     yes
22. Do you use any traditional or alternative medicines? no    yes
If you answered yes to any of the questions, please explain.
Page 2
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The following questions refer to your current or most recent job:
Job title: Describe this job:
Type of industry:
Name of employer:
Date job began:
Are you still working in this job?  yes     no
If no, when did this job end?
Part 2. Work History Name: ______________________________
A. Occupational Profile Birth date: __________________    Sex: Male   Female
Fill in the table below listing all jobs you have worked including short-term, seasonal, part-time employment, and military
service. Begin with your most recent job. Use additional paper if necessary.
*List the chemicals, dusts, fibers, fumes, radiation, biologic agents (i.e., molds or viruses) and physical agents (i.e., extreme
heat, cold, vibration, or noise) that you were exposed to at this job.
Have you ever worked at a job or hobby in which you came in contact with any of the following by breathing, touching, or
ingesting (swallowing)? If yes, please check the box beside the name.
Dates of Employment Job Title and Description of Work Exposures* Protective Equipment
Acids
Alcohols (industrial)
Alkalies
Ammonia
Arsenic
Asbestos
Benzene
Beryllium
Cadmium
Carbon tetrachloride
Chlorinated naphthalenes
Chloroform
Chloroprene
Chromates
Coal dust
Dichlorobenzene
Ethylene dibromide
Ethylene dichloride
Fiberglass
Halothane
Isocyanates
Ketones
Lead
Mercury
Methylene chloride
Nickel
PBBs
PCBs
Perchloroethylene
Pesticides
Phenol
Phosgene
Radiation
Rock dust
Silica powder
Solvents
Styrene
Talc
Toluene
TDI or MDI
Trichloroethylene
Trinitrotoluene
Vinyl chloride
Welding fumes
X-rays
Other (specify)
Developed by ATSDR in cooperation with NIOSH, 1992 Page 3
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B. Occupational Exposure Inventory Please circle the appropriate answer.
Part 3. Environmental History Please circle the appropriate answer.
1. Have you ever been off work for more than 1 day because of an illness related to work? no    yes
2. Have you ever been advised to change jobs or work assignments because of any health
problems or injuries? no    yes
3. Has your work routine changed recently? no    yes
1. Do you live next to or near an industrial plant, commercial business, dump site,
    or nonresidential property? no    yes
2. Which of the following do you have in your home?
    Please circle those that apply.
    Air conditioner Air purifier Central heating (gas or oil?) Gas stove Electric stove
    Fireplace Wood stove Humidifier
3. Have you recently acquired new furniture or carpet, refinished furniture, or remodeled
    your home? no    yes
4. Have you weatherized your home recently? no    yes
5. Are pesticides or herbicides (bug or weed killers; flea and tick sprays, collars, powders,
    or shampoos) used in your home or garden, or on pets? no    yes
6. Do you (or any household member) have a hobby or craft? no    yes
7. Do you work on your car? no    yes
8. Have you ever changed your residence because of a health problem? no    yes
9. Does your drinking water come from a private well, city water supply, or grocery store?
10. Approximately what year was your home built?_______________
If you answered yes to any of the questions, please explain.
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